Free cookie consent management tool by TermsFeed

Our Portfolio

Home > Our Portfolio 

Syncardia Systems
Series A
Preferred Equity
09/2012

Syncardia Systems

SynCardia Systems, Inc. is a private company formed in 2001 to commercialize the SynCardia temporary CardioWest™ Total Artificial Heart. Today, with more than 800 implants, the SynCardia Total Artificial Heart is the only FDA, Health Canada, and CE-approved Total Artificial Heart in the world.

More than 2,000 implants in over 20 countries and strong clinical data.

The first and only commercially available replacement device, to full functions of a human heart. Provides a new heart without the wait for patients with end-stage heart failure affecting both sides of the heart (biventricular failure).